why choose us

First received: June 08, 2023

Clinical Trial: Study of CM310 in Patients With Allergic Rhinitis

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Allergic Rhinitis

Study Type: INTERVENTIONAL


Official Title: A Multicenter, Single Arm Phase II Clinical Study Evaluating the Safety of CM310 Recombinant Humanized Monoclonal Antibody Injection in Patients With Seasonal Allergic Rhinitis

Brief Summary: This study is a multicenter, single arm, open-label phase II clinical study mainly evaluating the safety of CM310 in patients with allergic rhinitis.

Read more